Long term supporter of the company and SI.
Posting for first time.
I want to believe there should be a good reason for FDA to do what they did.
Could it be- That once approved for one indication, and in the hospital shelves, FDA is worried, doctors would be tempted (for good reason) to use it (off-label) for COVID-ARDS?
This could have implications for not only - Use without full evidence, supply constraints for the indication approved, manufacturing capacity not ready, etc.
So this could be a way to buy time, while they get more evidence for COVID use, which is probably their number 1 worry at the moment.
If it is, I am still positive.
Just delays my personal plans a little bit.
Not that I was in a rush to sell.
- Forums
- ASX - By Stock
- MSB
- Ann: Update on BLA for Graft Versus Host Disease
Ann: Update on BLA for Graft Versus Host Disease, page-243
-
-
- There are more pages in this discussion • 313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.5¢ |
Change
0.035(3.72%) |
Mkt cap ! $1.110B |
Open | High | Low | Value | Volume |
94.0¢ | 98.0¢ | 92.0¢ | $3.085M | 3.212M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 129058 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 133961 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 99264 | 0.970 |
16 | 221360 | 0.965 |
14 | 199378 | 0.960 |
10 | 234207 | 0.955 |
10 | 779652 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 110785 | 21 |
0.980 | 199734 | 23 |
0.985 | 80223 | 13 |
0.990 | 75752 | 6 |
0.995 | 68179 | 4 |
Last trade - 15.39pm 03/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online